SPL 0.00% 9.9¢ starpharma holdings limited

Competition for Viraleze?

  1. 3,359 Posts.
    lightbulb Created with Sketch. 171
    Here is a new innovation and it covers the problem of Viraleze only being in the nasal cavity.

    I think without any lab testing to prove viraleze effectiveness in the field, and the glaring problem that the virus can still enter through the mouth. Governments would lock onto this type of product first.

    There will be many many other products making there way onto the consumer space to compete with Viraleze, I believe this is the only reason the SP hasn't taken off. It was a massive pump and dump and now the low volumes are showing there simply isn't any interest and as the price returns closer to peoples buy in price they simply sell, dragging it lower.

    https://www.9news.com.au/videos/health/copper-face-mask-developed-by-innovators-may-destroy-coronavirus/ckoo2md6u000m0go5qpccpeiu
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.